Patient population for the NAVIGATE trial is based on non-invasive tests and clinical criteria utilizing latest treatment guidelines for portal hypertension in MASH cirrhosisBlinded central review ...

Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) including ulcerative colitis, today ...

Over 40% of participants treated with EFX 50mg for 96 weeks, compared with 0% for placebo, showed regression of liver ...

Transplant rates and waitlist dropouts for women are now similar to those for men, yet some disparities still exist.

Readouts from Novo Nordisk and Viking Therapeutics at AASLD 2024 strengthen the argument for GLP-1 therapies as an emerging ...

Since MELD 3.0 was implemented in July 2023, a higher proportion of women are now on the liver transplant waitlist, and ...

Title: ALG-055009, a Novel Thyroid Hormone Receptor Beta (THR-β) Agonist, was Well-tolerated with Significant Reductions in ...

William Blair has the equivalent of a buy rating on the stock, as do all 13 analysts offering coverage of the stock on FactSet. The bank is one of many expecting Viking to be a takeover target, given ...

Vir Biotechnology (VIR) announced results from the SOLSTICE Phase 2 clinical trial evaluating tobevibart alone, or in combination with ...

A new study has found that people who only drink beer tend to have much worse diets than those who prefer wine, spirits, or a ...

A recent study has sounded the alarm for beer lovers, suggesting that their food choices might not be up to par with those ...

While having HDL levels above 60 mgdL is often seen as a sign of good health it’s not a standalone indicator Read ahead to ...